Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without
agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 …

Fluoxetine is a new antidepressant with pharmacologic effects apparently limited to
blockade of neuronal serotonin reuptake. We entered 20 patients who met DSM-III criteria …

Background Recent reports suggest that fluoxetine in doses less than the standard 20
mg/day may be effective in the treatment of depression and that some patients, particularly …

Several reports suggest that selective serotonin reuptake blockers are helpful in the
treatment of panic disorder. The aim of the study was to compare fluvoxamine with placebo …

Serotonergic mechanisms have been implicated in panic disorder, and several preliminary
studies suggest that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI), is helpful in …

A double-blind comparative study with fluvoxamine, a specific serotonin uptake inhibitor.
and maprotiline, a specific noradrenaline uptake inhibitor, was conducted in 44 patients …

BackgroundAlthough serotonin reuptake inhibitors are effective in panic disorder, questions
concerning whether doses associated with antidepressant efficacy are also effective for …

An international, multicentre, double blind parallel group study compared the tolerability and
efficacy of moclobemide with the selective serotonin reuptake inhibitor (SSRI) fluoxetine for …

Selective serotonin reuptake inhibitors (SSRI) have been established as effective drugs in
the treatment of depressive and anxiety disorders. However, there are also reports that they …

OBJECTIVE: This study was designed to determine the minimum paroxetine dose effective
for treating panic disorder. METHOD: Of 425 patients with DSM-III-R panic disorder with or …